rs17468277
Orientation | plus |
Stabilized | plus |
Geno | Mag | Summary |
---|---|---|
(C;C) | 0 | common in clinvar |
Make rs17468277(C;T) |
Make rs17468277(T;T) |
Reference | GRCh38 38.1/141 |
Chromosome | 2 |
Position | 201289477 |
Gene | ALS2CR12 |
is a | snp |
is | mentioned by |
dbSNP | rs17468277 |
dbSNP (classic) | rs17468277 |
ClinGen | rs17468277 |
ebi | rs17468277 |
HLI | rs17468277 |
Exac | rs17468277 |
Gnomad | rs17468277 |
Varsome | rs17468277 |
LitVar | rs17468277 |
Map | rs17468277 |
PheGenI | rs17468277 |
Biobank | rs17468277 |
1000 genomes | rs17468277 |
hgdp | rs17468277 |
ensembl | rs17468277 |
geneview | rs17468277 |
scholar | rs17468277 |
rs17468277 | |
pharmgkb | rs17468277 |
gwascentral | rs17468277 |
openSNP | rs17468277 |
23andMe | rs17468277 |
SNPshot | rs17468277 |
SNPdbe | rs17468277 |
MSV3d | rs17468277 |
GWAS Ctlg | rs17468277 |
GMAF | 0.06566 |
Max Magnitude | 0 |
? | (C;C) (C;T) (T;T) | 28 |
---|---|---|
|
[PMID 20145138] Common genetic variants associated with breast cancer and mammographic density measures that predict disease
[PMID 21596841] Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium.
[PMID 22532573] The role of genetic breast cancer susceptibility variants as prognostic factors.
[PMID 23479381] Breast cancer susceptibility loci in association with age at menarche, age at natural menopause and the reproductive lifespan
[PMID 23704029] Breast cancer susceptibility loci in association with age at menarche, age at natural menopause and the reproductive lifespan
ClinVar | |
---|---|
Risk | rs17468277(T;T) |
Alt | rs17468277(T;T) |
Reference | Rs17468277(C;C) |
Significance | Non-pathogenic |
Disease | not specified |
Variation | info |
Gene | ALS2CR12 |
CLNDBN | not specified |
Reversed | 0 |
HGVS | NC_000002.11:g.202154200C>T |
CLNSRC | |
CLNACC | RCV000455346.1, |
[PMID 28757652] Genetic Breast Cancer Susceptibility Variants and Prognosis in the Prospectively Randomized SUCCESS A Study.